Long‐term response to crizotinib in a 17‐year‐old boy with treatment‐naïve ALK‐positive non‐small‐cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long‐term response to crizotinib in a 17‐year‐old boy with treatment‐naïve ALK‐positive non‐small‐cell lung cancer

Published:2022-01-28 Issue:3 Volume:5 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Megaro Giacomina¹^ORCID,Miele Evelina¹^ORCID,Spinelli Gian Paolo²,Alessi Iside¹,Del Baldo Giada¹,Cozza Raffaele¹,Russo Ida¹,De Pasquale Maria Debora¹,Cefalo Maria Giuseppina¹,Tomà Paolo³,Carai Andrea⁴,Di Ruscio Valentina¹,De Ioris Maria Antonietta¹,Mastronuzzi Angela¹

Affiliation:

1. Department of Hematology/Oncology, Cell and Gene Therapy IRCCS Bambino Gesù Children's Hospital Rome Italy

2. UOC Oncologia Universitaria, ASL Latina (distretto Aprilia) Sapienza University of Rome‐ Aprilia Latina Italy

3. Department of Imaging Bambino Gesù Children's Hospital, IRCCS Rome Italy

4. Neurosurgery Unit, Department of Neuroscience Bambino Gesù Children's Hospital, IRCCS Rome Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1483

Reference31 articles.

1. I numeri del cancro in Italia 2018.AIOM‐AIRTUM

2. Epidemiology of Lung Cancer: Looking to the Future

3. Incidence and Outcomes of Malignant Pediatric Lung Neoplasms

4. Global cancer statistics

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crizotinib;Reactions Weekly;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP